Medicare Enrolled

Dr. Emanuele Santomauro, MD

Pulmonary Disease · Hackensack, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
211 ESSEX ST, Hackensack, NJ 07601
2014981311
In practice since 2006 (19 years)
NPI: 1053485243 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Santomauro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Santomauro? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Santomauro

Dr. Emanuele Santomauro is a pulmonary disease specialist in Hackensack, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Santomauro performed 3,269 Medicare services across 1,854 unique beneficiaries.

Between the years covered by Open Payments, Dr. Santomauro received a total of $356,834 from 49 pharmaceutical and/or device companies across 1326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Santomauro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 13% volume in NJ $356,834 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,269
Medicare services
Top 13% in NJ for pulmonary disease
1,854
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~172 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,276 $105 $434
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
947 $68 $242
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
171 $135 $564
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
125 $148 $626
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
118 $50 $212
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
116 $39 $158
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
112 $35 $139
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
97 $34 $104
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
92 $72 $110
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
69 $101 $345
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
63 $43 $136
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $74 $309
Respiratory virus test for SARS-CoV-2, influenza A/B, and RSV
A laboratory test that detects the presence of SARS-CoV-2 (COVID-19), influenza A, influenza B, and respiratory syncytial virus (RSV) in an upper respiratory specimen.
16 $140 $430
Bronchial irrigation and suction for cell collection
This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing.
16 $58 $908
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$356,834
Total received (2018-2024)
Avg $50,976/year across 7 years
Top 1% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
1,326
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$340,991 (95.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,984 (2.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,858 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$84,310
2023
$69,826
2022
$39,044
2021
$79,577
2020
$32,413
2019
$29,970
2018
$21,694

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$54,203
Mylan Specialty L.P.
$13,978
Regeneron Healthcare Solutions, Inc.
$8,266
GlaxoSmithKline, LLC.
$6,300
Amgen Inc.
$319
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
Insmed, Inc.
$185
Philips North America LLC
$98
Grifols USA, LLC
$82
Actelion Pharmaceuticals US, Inc.
$80
SANOFI-AVENTIS U.S. LLC
$79
Novartis Pharmaceuticals Corporation
$76
GENZYME CORPORATION
$67
Mallinckrodt Hospital Products Inc.
$55
Merck Sharp & Dohme LLC
$53
United Therapeutics Corporation
$47
JAZZ PHARMACEUTICALS INC.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$41
HARMONY BIOSCIENCES LLC
$33
Harmony Biosciences Llc
$30
ANI Pharmaceuticals, Inc.
$15
Top 3 companies account for 90.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$142,124
GlaxoSmithKline, LLC.
$119,294
Regeneron Healthcare Solutions, Inc.
$46,024
Mylan Specialty L.P.
$17,235
Amgen Inc.
$8,566
Boehringer Ingelheim Pharmaceuticals, Inc.
$8,112
PFIZER INC.
$5,781
Acerta Pharma LLC
$1,967
Teva Pharmaceuticals USA, Inc.
$1,806
Actelion Pharmaceuticals US, Inc.
$655
Grifols USA, LLC
$631
Genentech USA, Inc.
$586
Insmed, Inc.
$548
E.R. Squibb & Sons, L.L.C.
$514
Philips Electronics North America Corporation
$314
Sunovion Pharmaceuticals Inc.
$282
Novartis Pharmaceuticals Corporation
$279
GENZYME CORPORATION
$251
Pulmonx Corporation
$184
Mallinckrodt Hospital Products Inc.
$165
Shire North American Group Inc
$135
United Therapeutics Corporation
$126
Gilead Sciences, Inc.
$109
Merck Sharp & Dohme Corporation
$101
Philips North America LLC
$98
JAZZ PHARMACEUTICALS INC.
$89
Merck Sharp & Dohme LLC
$86
SANOFI-AVENTIS U.S. LLC
$79
Takeda Pharmaceuticals U.S.A., Inc.
$74
Bayer Healthcare Pharmaceuticals Inc.
$72
Bayer HealthCare Pharmaceuticals Inc.
$68
Baxter Healthcare
$54
Harmony Biosciences LLC
$49
Janssen Pharmaceuticals, Inc
$49
Jazz Pharmaceuticals Inc.
$35
HARMONY BIOSCIENCES LLC
$33
ANI Pharmaceuticals, Inc.
$32
Harmony Biosciences Llc
$30
Mallinckrodt Enterprises LLC
$30
Exeltis, USA Inc.
$29
Covidien LP
$21
Lilly USA, LLC
$18
Allergan Inc.
$17
Covis Pharma GmBH
$15
ALK-Abello, Inc
$15
Circassia Pharmaceuticals Inc
$14
Mallinckrodt LLC
$12
Kowa Pharmaceuticals America, Inc.
$12
Veran Medical Technologies, Inc.
$11
Top 3 companies account for 86.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALVESCO · ANDEXXA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · ASMANEX · Adempas · AirDuo Digihaler · Arikayce · ArmonAir Digihaler · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · BYSTOLIC · CHANTIX · CHARTIS CATHETER · CINQAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · KEYTRUDA · LONHALA MAGNAIR · Letairis · Livalo · MOUNJARO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Odactra · PULMICORT RESPULES · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QVAR · Respiratoriy Care Undiv · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · Utibron · WAKIX · WINREVAIR · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xembify · Xolair · Xyrem · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZERBAXA · inCourage · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pulmonary disease in NJ.

Looking for a pulmonary disease specialist in Hackensack?
Compare pulmonary diseases in the Hackensack area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
650
Per 100K population
68.1
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Santomauro is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NJ), with speaking/promotional industry engagement in the top 1% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Santomauro experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Santomauro performed 1,276 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Santomauro receive payments from pharmaceutical companies?
Yes. Dr. Santomauro received a total of $356,834 from 49 companies across 1,326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Santomauro's costs compare to other pulmonary diseases in Hackensack?
Dr. Santomauro's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Santomauro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →